FinancialContent

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Assessing Regeneron Pharmaceuticals: Insights From 7 Financial Analysts
Tickers REGN
Tags Market News BZI/AAR Benzinga
From Benzinga
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Tickers ABBV AZN BIIB BMRN
Tags BMRN VRTX BMY
From Benzinga
Sanofi Asthma Drug Misses Primary Goal, Plans For Pivotal Study
Tickers NEWS REGN SNY
Tags News Market News Health Care
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Tickers ABBV AMGN BMY FTXH
Tags reciprocal tariffs JNJ FTXH
From Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Tickers ARGX AZN GILD GSK
Tags UCBJY RDY Top Stories
From Benzinga
Is Regeneron Pharmaceuticals Gaining or Losing Market Support?
Tickers REGN
Tags Market News Short Ideas Short Sellers
From Benzinga
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
Tickers CRSP IOVA REGN SRPT
Tags IOVA CRSP SRPT
From Motley Fool
3 Growth Stocks That Have Turned $1,000 Into More Than $100,000 in 20 Years
Tickers AAPL BKNG REGN
Tags Market News BKNG AAPL
From Motley Fool
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
Tickers ALNY AMGN BIIB GILD
Tags Briefs Health Care GILD
From Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Tickers NEWS REGN
Tags Benzinga BZI/POD REGN
From Benzinga
Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors
Tickers NEWS REGN SNSE
Tags Health Care News Market News
From Benzinga
Why Pharma and Biotech Stocks Got Thrashed on Tuesday
Tickers AMGN AXSM MRK REGN
Tags REGN AXSM Recent Press Releases
From Motley Fool
Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
Tickers NEWS REGN UBX
Tags REGN why it's moving Health Care
From Benzinga
Opthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial Uncertainty
Tickers NEWS OPT REGN
Tags REGN Market News News
From Benzinga
Price Over Earnings Overview: Regeneron Pharmaceuticals
Tickers NEWS REGN
Tags BZI/PE Benzinga Markets
From Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today
Tickers NEWS REGN
Tags Benzinga Market News News
From Benzinga
Amgen And Kyowa Kirin's Rocatinlimab Reduces Eczema Severity In Phase 3 Study
Tickers AMGN LLY NEWS REGN
Tags SNY REGN Market News
From Benzinga
1 Dividend Stock Down 30% to Buy and Hold for the Next Decade
Tickers REGN
Tags Recent Press Releases REGN Market News
From Motley Fool
Eli Lilly's Single Monthly Maintenance Shot Of Eczema Drug Shows Completely Clear Skin At 3 Years In 50% Of Trial Patients
Tickers LLY NEWS REGN SNY
Tags Benzinga Biotech LLY
From Benzinga
Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial
Tickers APGE NEWS REGN SNY
Tags APGE Top Stories Trading Ideas
From Benzinga
Regeneron Touts Encouraging Early Data From Investigational Gene Therapy For Rare Form Of Hearing Loss
Tickers NEWS REGN
Tags REGN Market News News
From Benzinga
Price Over Earnings Overview: Regeneron Pharmaceuticals
Tickers NEWS REGN
Tags Benzinga BZI/PE Intraday Update
From Benzinga
This Company Just Initiated a Quarterly Dividend: Time to Buy?
Tickers REGN
Tags Recent Press Releases REGN Market News
From Motley Fool
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
Tickers REGN
Tags Short Ideas Market News REGN
From Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
Tickers NEWS REGN
Tags Benzinga BZI/POD REGN
From Benzinga
Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study
Tickers FDMT NEWS REGN
Tags Trading Ideas News Market News
From Benzinga
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
Tickers AMGN CRSP REGN
Tags Market News REGN AMGN
From Motley Fool
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Tickers NEWS REGN
Tags Benzinga News Market News
From Benzinga
Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
Tickers REGN SNY
Tags SNY Recent Press Releases REGN
From Motley Fool
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
Tickers ADM AMCR AMD AME
Tags GPK RACE CSL
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >